Rossari Biotech

Rossari Biotech Debt/EBITDA

The Total Debt to EBITDA Ratio of Rossari Biotech (ROSSARI.NS) as of Nov 2, 2026 is 2.11. In the previous year, Total Debt to EBITDA Ratio was 0.37 — a change of 462.59% (higher).

Debt/EBITDA

2.11

YoY

462.59%

Last updated:

Total Debt to EBITDA Ratio of Rossari Biotech is 2026 2.11 . Total Debt to EBITDA Ratio of Rossari Biotech was 2025 0.37 . It decreases by 462.59% higher compared to the previous year.

The Rossari Biotech Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2019
0.06 INR
Jan 1, 2020
0.64 INR
Jan 1, 2021
0.06 INR
Jan 1, 2022
0.04 INR
Jan 1, 2023
0.34 INR
Jan 1, 2024
0.48 INR
Jan 1, 2025
0.37 INR
Jan 1, 2026
2.11 INR
The Rossari Biotech Debt/EBITDA history
YEARDebt/EBITDAYoY
2.11+462.59%
0.37-22.09%
0.48+41.78%
0.34+675.90%
0.04-32.04%
0.06-89.93%
0.64+998.29%
0.06-88.14%
0.49-53.98%
1.07-49.49%
2.11—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Rossari Biotech Stock analysis

What does Rossari Biotech do? Rossari Biotech Ltd. generates revenue by manufacturing and distributing specialty chemicals across three segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals (TSC), and Animal Health and Nutrition (AHN). The HPPC segment produces acrylic polymers for cleaning industry applications, while TSC offers eco-friendly solutions for textile pre-treatment, dyeing, printing, and finishing. AHN provides wellness solutions for pet animals and poultry, targeting health and performance needs. Global brands in the FMCG sector, consumer products, and textile industries purchase these chemicals for use in home and personal care, cosmetics, and animal health products. The company's products are designed for global FMCG brands, textile manufacturers, and animal health providers, with applications spanning home and personal care, cosmetics, textile processing, and animal nutrition. TSC's focus on sustainable chemical solutions aligns with textile industry demands for eco-friendly products, while AHN's pet and poultry wellness solutions cater to growing markets in animal health. HPPC's acrylic polymers support cleaning product formulations used in consumer goods. Rossari Biotech Ltd. serves customers in the global FMCG sector, textile industry, and animal health markets, delivering specialty chemicals that enable product formulations for home care, personal care, textiles, and animal nutrition. The company's sustainable product range in HPPC and TSC appeals to environmentally conscious buyers in the consumer goods and textile sectors, while AHN's solutions target pet and poultry health markets. Rossari Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rossari Biotech stock

Total Debt to EBITDA Ratio of Rossari Biotech is 2.11 in 2026.

Total Debt to EBITDA Ratio of Rossari Biotech changed from 0.37 to 2.11, representing a 462.59% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Rossari Biotech since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Rossari Biotech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Rossari Biotech

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Rossari Biotech